Related Experiment Video
Updated: Oct 6, 2026

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
Ras-associated autoimmune leukoproliferative disorder associated with immune thrombotic thrombocytopenic purpura
Matthew A Carter1,2, Andrew J Innes3, Monica Sen1
1Haemostasis Research Unit, Institute of Cardiovascular Science, University College London, London, UK.
Background:
Ras-associated autoimmune leukoproliferative disorder (RALD) is a rare, nonmalignant condition characterized by monocytosis, lymphoproliferation, and autoimmunity, driven by KRAS or NRAS variants. Immune thrombotic thrombocytopenic purpura (iTTP) results from autoantibodies against ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13).
Key Clinical Question:
Can RALD co-occur with iTTP, and how can it be diagnosed?
Clinical Approach:
A patient presenting with neutropenia, monocytosis, and thrombocytopenia was initially diagnosed with chronic myelomonocytic leukemia. She later developed splenomegaly, lymphadenopathy, and iTTP. Reevaluation identified a somatic KRAS G12A variant in peripheral blood, prompting a diagnosis of RALD. Flow cytometry demonstrated immunophenotypic changes involving B cells, T cells, and monocytes. The patient had four ADAMTS13 relapses, responsive to rituximab.
Conclusion:
This case highlights co-occurrence of RALD and iTTP, extending the spectrum of Ras-associated autoimmune cytopenias.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction
Graves' Disease I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Hypersensitivity Reactions: Immune-Complex Reactions